Clinical trial
Egg Effects on Atherogenic Dyslipidemia, Glucose Metabolism and Inflammation in Diabetic Subjects
NCT02181244 is registered in ClinicalTrials.gov with University of Connecticut as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Egg Effects on Atherogenic Dyslipidemia, Glucose Metabolism and Inflammation in Diabetic Subjects
- Lead sponsor
- University of Connecticut
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 31, 2013
- Completion date
- June 30, 2014
- Enrollment
- 33 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.